| 000 | 01501 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515181809.0 | ||
| 264 | 0 | _c20091008 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1488-2353 | ||
| 024 | 7 |
_a10.25011/cim.v32i4.6618 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLjubic, Spomenka | |
| 245 | 0 | 0 |
_aAdiponectin has different mechanisms in type 1 and type 2 diabetes with C-peptide link. _h[electronic resource] |
| 260 |
_bClinical and investigative medicine. Medecine clinique et experimentale _cAug 2009 |
||
| 300 |
_aE271-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdiponectin _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 |
_aUric Acid _xblood |
| 700 | 1 | _aBoras, Jozo | |
| 700 | 1 | _aJazbec, Anamarija | |
| 700 | 1 | _aLovrencic, Marijana Vucic | |
| 700 | 1 | _aVidjak, Vinko | |
| 700 | 1 | _aErzen, Dubravka Jurisic | |
| 700 | 1 | _aMileta, Dean | |
| 773 | 0 |
_tClinical and investigative medicine. Medecine clinique et experimentale _gvol. 32 _gno. 4 _gp. E271-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.25011/cim.v32i4.6618 _zAvailable from publisher's website |
| 999 |
_c19048126 _d19048126 |
||